LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.11 | 771.67 | 2999 | 2675 | 1.1211 | 1.1316 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.33 | 771.67 | 2823 | 2939 | 0.9604 | 0.9586 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.33 | 771.67 | 3326 | 2939 | 1.1315 | 1.1323 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.55 | 771.67 | 3079 | 3196 | 0.9632 | 0.9637 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.55 | 771.67 | 3687 | 3196 | 1.1534 | 1.1441 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.78 | 771.67 | 3360 | 3499 | 0.9601 | 0.9630 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.78 | 771.67 | 3989 | 3499 | 1.1398 | 1.1237 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.00 | 771.67 | 3672 | 3884 | 0.9452 | 0.9523 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.00 | 771.67 | 4235 | 3884 | 1.0902 | 1.0754 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.22 | 771.67 | 3994 | 4299 | 0.9289 | 0.9414 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.22 | 771.67 | 4615 | 4299 | 1.0733 | 1.0580 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.44 | 771.67 | 4309 | 4738 | 0.9094 | 0.9287 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 40.44 | 771.67 | 5085 | 4738 | 1.0732 | 1.0547 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.67 | 771.67 | 4742 | 5155 | 0.9198 | 0.9399 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.67 | 771.67 | 5483 | 5155 | 1.0635 | 1.0454 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.89 | 771.67 | 5073 | 5541 | 0.9155 | 0.9388 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.89 | 771.67 | 5916 | 5541 | 1.0676 | 1.0465 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.11 | 771.67 | 5531 | 5941 | 0.9309 | 0.9520 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.11 | 771.67 | 6328 | 5941 | 1.0651 | 1.0433 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.33 | 771.67 | 5900 | 6392 | 0.9229 | 0.9481 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.33 | 771.67 | 6665 | 6392 | 1.0426 | 1.0275 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.55 | 771.67 | 6174 | 6829 | 0.9040 | 0.9368 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.55 | 771.67 | 6960 | 6829 | 1.0191 | 1.0120 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.77 | 771.67 | 6525 | 7256 | 0.8992 | 0.9354 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.77 | 771.67 | 7384 | 7256 | 1.0176 | 1.0108 | MN20160304_L01 | J07 |